The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten
- PMID: 5430788
- PMCID: PMC2138777
- DOI: 10.1084/jem.131.4.783
The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten
Abstract
Hapten-antibody complexes prepared at equivalence with the bivalent hapten bis-DNP-octamethylene-diamine and purified rabbit anti-DNP antibody were fractionated by Sepharose gel-filtration and the fractions examined by electron microscopy. Individual fractions were tested for whole-complement fixation and C1 fixation. Dimer forms did not show this type of biological activity, while fractions containing tetramers and larger polymers exhibited both C and C1 fixation, which could be inhibited by prior exposure of the complexes to the univalent hapten epsilon-DNP-caproic acid. The dose-response result indicated that the C-fixation observed was not due to interpolymeric cooperative effects. It was concluded that in the generation of biological activity by soluble antigen-antibody complexes made with complement-fixing antibody, quaternary structural changes following specific combination with antigen may be as important as any tertiary structural alterations that occur in the individual immunoglobulin molecule.
Similar articles
-
Complement activation by a univalent hapten-antibody complex.J Biol Chem. 1975 Jul 10;250(13):4918-25. J Biol Chem. 1975. PMID: 1171093
-
The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.J Immunol. 1977 Jun;118(6):2182-91. J Immunol. 1977. PMID: 559020 No abstract available.
-
The binding of complement by complexes formed between a rabbit antibody and oligosaccharides of increasing size.J Immunol. 1976 May;116(5):1363-6. J Immunol. 1976. PMID: 5560
-
The active sites of immunoglobulin molecules.Essays Fundam Immunol. 1973;0(1):1-27. Essays Fundam Immunol. 1973. PMID: 4137966 Review. No abstract available.
-
Methods for the detection of soluble circulating immune complexes and their application.Pathobiol Annu. 1979;9:113-36. Pathobiol Annu. 1979. PMID: 384334 Review. No abstract available.
Cited by
-
Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.Immunology. 1982 Apr;45(4):705-13. Immunology. 1982. PMID: 7068172 Free PMC article.
-
Soluble oligovalent antigen-antibody complexes. I. The effect of antigen valence and combining ratio on the composition of fluorescein-carrier anti-fluorescein complexes.Immunology. 1979 Jun;37(2):485-93. Immunology. 1979. PMID: 468312 Free PMC article.
-
Membrane-controlled depletion of complement activity by spin-label-specific IgM.Proc Natl Acad Sci U S A. 1977 Aug;74(8):3537-41. doi: 10.1073/pnas.74.8.3537. Proc Natl Acad Sci U S A. 1977. PMID: 198789 Free PMC article.
-
C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.Immunology. 1983 Jun;49(2):215-22. Immunology. 1983. PMID: 6852866 Free PMC article.
-
Preparation and characterization of chemically defined oligomers of rabbit immunoglobulin G molecules for the complement binding studies.Biochem J. 1980 Jun 1;187(3):767-74. doi: 10.1042/bj1870767. Biochem J. 1980. PMID: 7188424 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous